P26368 (U2AF2_HUMAN) Homo sapiens (Human)
Splicing factor U2AF 65 kDa subunit UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
37 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Solution Structure of the third RNA Recognition Motif (RRM) of U2AF65 in complex with an N-terminal… |
Heteromer Q15637; | |||||
| Assess | ||||||
| Structure, phosphorylation and U2AF65 binding of the Nterminal Domain of splicing factor 1 during 3… |
Heteromer Q15637; | |||||
| Assess | ||||||
| SOLUTION STRUCTURE OF THE THIRD RNA RECOGNITION MOTIF (RRM) OF U2AF65 IN COMPLEX WITH AN N-TERMINAL… |
Heteromer Q15637; | |||||
| Assess | ||||||
| U2AF65 UHM BOUND TO SF3B155 ULM5 |
Heteromer O75533; | |||||
| Assess | ||||||
| Structure of phosphorylated SF1 complex with U2AF65-UHM domain |
Heteromer Q15637; | 2×SO4; | ||||
| Assess | ||||||
| X-ray Structure of a Core U2AF65/U2AF35 Heterodimer |
Heteromer Q01081; | 2×HEZ; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU5C1 DNA | homo-4-mer | 4×DIO; 11×SO4; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with polyuridine tract | homo-2-mer | 2×DIO; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU5C6 DNA | homo-2-mer | 5×DIO; 6×SO4; 2×GOL; 1×CPQ; | ||||
| Assess | ||||||
| STRUCTURE OF U2AF65 VARIANT WITH BRU5A6 DNA | homo-2-mer | 7×DIO; 1×GOL; 9×EDO; 3×SO4; 1×CPQ; | ||||
| Assess | ||||||
| STRUCTURE OF U2AF65 VARIANT WITH BRU5G6 DNA | homo-2-mer | 5×DIO; 6×SO4; 2×GOL; 1×CPQ; | ||||
| Assess | ||||||
| Structure of U2AF65 D231V variant with BrU5 DNA | homo-2-mer | 4×DIO; 6×SO4; 4×GOL; 1×CPQ; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU5 DNA | homo-2-mer | 5×DIO; 7×SO4; 4×GOL; 1×CPQ; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU3C2 DNA | homo-2-mer | 6×DIO; 7×SO4; 2×GOL; 1×CPQ; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU3C5 DNA | homo-2-mer | 5×DIO; 7×SO4; 1×CPQ; 1×GOL; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU5C2 DNA | homo-2-mer | 5×DIO; 5×SO4; 2×GOL; 1×CPQ; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU3 DNA | homo-2-mer | 4×DIO; 6×SO4; 1×GOL; 1×CPQ; | ||||
| Assess | ||||||
| Structure of U2AF65 variant with BrU3C4 DNA | homo-2-mer | 4×DIO; 5×SO4; 1×CPQ; 1×GOL; | ||||
| Assess | ||||||
| Solution structure of U2AF2 RRM1,2 | monomer | |||||
| Assess | ||||||
| Crystal structure of leukemia-associated N196K mutant of U2AF65 bound to AdML splice site | monomer | |||||
| Assess | ||||||
| Crystal structure of intact U2AF65 RRM-region bound to AdML-G5 oligonucleotide | monomer | 2×PEG; | ||||
| Assess | ||||||
| Crystal structure of intact U2AF65 RRM-region bound to AdML-C5 oligonucleotide | monomer | 3×NA; | ||||
| Assess | ||||||
| Crystal structure of U2AF65 bound to AdML splice site sequence | monomer | 1×GOL; 1×PEG; 4×NA; | ||||
| Assess | ||||||
| Crystal structure of intact U2AF65 RRM-region bound to AdML-A5 oligonucleotide | monomer | |||||
| Assess | ||||||
| Structure II of Intact U2AF65 Recognizing the 3' Splice Site Signal | monomer | 1×DIO; 1×PGE; 1×PEG; | ||||
| Assess | ||||||
| Structure I of Intact U2AF65 Recognizing a 3' Splice Site Signal | monomer | 2×NA; 1×PGE; 1×PEG; | ||||
| Assess | ||||||
| Structure IV of Intact U2AF65 Recognizing the 3' Splice Site Signal | monomer | 1×GOL; | ||||
| Assess | ||||||
| Structure III of Intact U2AF65 Recognizing the 3' Splice Site Signal | monomer | |||||
| Assess | ||||||
| Crystal structure of cancer-associated G301D mutant of U2AF65 bound to AdML splice site | monomer | |||||
| Assess | ||||||
| Solution structure of the closed conformation of human U2AF65 tandem RRM1 and RRM2 domains | monomer | |||||
| Assess | ||||||
| Model of human U2AF65 tandem RRM1 and RRM2 domains with eight-site uridine binding | monomer | |||||
| Assess | ||||||
| Solution structure of a chimeric U2AF2 RRM2 / FUBP1 N-Box | monomer | |||||
| Assess | ||||||
| SOLUTION STRUCTURE OF THE FIRST RNA-BINDING DOMAIN OF HU2AF65 | monomer | |||||
| Assess | ||||||
| SOLUTION STRUCTURE OF THE SECOND RNA-BINDING DOMAIN OF HU2AF65 | monomer | |||||
| Assess | ||||||
| Structure of U2AF65 (U2AF2) RRM1 at 1.07 resolution | monomer | 2×ZN; 1×ACT; 1×1PG; | ||||
| Assess | ||||||
| Crystal structure of the N-terminal RRM of the U2AF large subunit | monomer | 2×ZN; 1×P6G; | ||||
| Assess | ||||||
| Structure of U2AF65 (U2AF2) RRM2 at 1.11 Angstrom Resolution | monomer | |||||
| Assess | ||||||
7 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6xlw.1.A | monomer | 0.78 | 1×U; | 100.00 | ||
| Assess | ||||||
| 6tr0.1.A | monomer | 0.69 | 100.00 | |||
| Assess | ||||||
| 6wmz.1.A | monomer | 0.58 | 24.68 | |||
| Assess | ||||||
| 3to8.1.A | monomer | 0.56 | 18.85 | |||
| Assess | ||||||
| 4pkd.1.B | monomer | 0.56 | 18.18 | |||
| Assess | ||||||
| 7oqc.1.A | monomer | 0.54 | 16.28 | |||
| Assess | ||||||
| 4pkd.1.B | monomer | 0.50 | 17.26 | |||
| Assess | ||||||
6 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6xlw.1.A | monomer | 0.81 | 1×U; | 100.00 | |
| Assess | ||||||
| Isoform 2 | 6tr0.1.A | monomer | 0.71 | 100.00 | ||
| Assess | ||||||
| Isoform 2 | 6wmz.1.A | monomer | 0.58 | 24.68 | ||
| Assess | ||||||
| Isoform 2 | 4pkd.1.B | monomer | 0.56 | 18.18 | ||
| Assess | ||||||
| Isoform 2 | 4wii.1.A | monomer | 0.54 | 22.44 | ||
| Assess | ||||||
| Isoform 2 | 4pkd.1.B | monomer | 0.53 | 17.10 | ||
| Assess | ||||||